全球職業篩檢市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計帶因者篩檢市場將從 2025 年的 19.3 億美元成長到 2034 年的 57.6 億美元，2026 年至 2034 年的複合年成長率為 12.91%。

基因檢測在生殖醫學領域的重要性日益凸顯，帶動了全球帶因者篩檢市場的快速成長。帶因者篩檢有助於識別攜帶可能導致子女患遺傳性疾病的基因突變的個體。這些檢測常用於囊腫纖維化、脊髓性肌肉萎縮症和其他遺傳性疾病的篩檢。

市場成長的促進因素包括人們對遺傳疾病認知的提高以及對早期檢測需求的日益成長。基因組技術的進步和基因檢測成本的降低使得攜帶者篩檢更容易被病人接受。醫療保健專業人員也擴大向計劃懷孕的夫婦推薦這些檢測。

隨著個人化醫療和基因檢測的日益普及，攜帶者篩檢市場預計將顯著成長。次世代定序技術的進步將提高篩檢的準確性和效率。基因研究投入的增加和醫療基礎設施的擴建也將支撐該市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球職業篩檢市場：依類型分類

• 市場分析、洞察與預測
• 擴展攜帶者篩檢
• 針對特定疾病的帶因者篩檢

第5章 全球帶因者篩檢市場：依疾病分類

• 市場分析、洞察與預測
• 囊腫纖維化
• 戴-薩克斯病
• 高雪氏症
• 鐮狀細胞貧血症
• 脊髓性肌肉萎縮症
• 其他

第6章 全球載體篩檢市場：依技術分類

• 市場分析、洞察與預測
• DNA定序
• 聚合酵素鏈鎖反應
• 微陣列
• 其他

第7章 全球職業篩檢市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 研究所
• 診所和醫療辦公室
• 其他

第8章 全球職業篩檢市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Myriad Genetics Inc
  • Cepheid
  • Illumina
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Laboratory Corporation Of America Holdings
  • Otogenetics
  • MedGenome
  • GeneTech
  • Centogene NV

The Carrier Screening Market size is expected to reach USD 5.76 Billion in 2034 from USD 1.93 Billion (2025) growing at a CAGR of 12.91% during 2026-2034.

The global carrier screening market is witnessing rapid growth due to the increasing importance of genetic testing in reproductive health. Carrier screening tests help identify individuals who carry genetic mutations that may cause inherited diseases in their children. These tests are commonly used for conditions such as cystic fibrosis, spinal muscular atrophy, and other genetic disorders.

The growth of this market is driven by rising awareness about genetic disorders and the growing demand for early detection of inherited conditions. Advances in genomic technologies and the decreasing cost of genetic testing have made carrier screening more accessible to patients. Healthcare providers are increasingly recommending these tests to couples planning pregnancy.

Looking ahead, the carrier screening market is expected to expand significantly as personalized medicine and genetic testing become more widely adopted. Advances in next-generation sequencing technologies will improve the accuracy and efficiency of screening tests. Increasing investments in genetic research and expanding healthcare infrastructure will also support the long-term growth of this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Expanded Carrier Screening
• Targeted Disease Carrier Screening

By Medical Condition

• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Other

By Technology

• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Other

By End-user

• Hospitals
• Laboratories
• Physician Offices & Clinics
• Other

COMPANIES PROFILED

• Myriad Genetics Inc, Cepheid, Illumina, Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Laboratory Corporation of America Holdings, Otogenetics, MedGenome, GeneTech, Centogene NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARRIER SCREENING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Expanded Carrier Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Targeted Disease Carrier Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARRIER SCREENING MARKET: BY MEDICAL CONDITION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Medical Condition
• 5.2. Cystic Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tay-Sachs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gaucher Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Sickle Cell Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Spinal Muscular Atrophy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARRIER SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Polymerase Chain Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARRIER SCREENING MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Physician Offices & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARRIER SCREENING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Medical Condition
  • 8.2.3 By Technology
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Medical Condition
  • 8.3.3 By Technology
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Medical Condition
  • 8.4.3 By Technology
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Medical Condition
  • 8.5.3 By Technology
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Medical Condition
  • 8.6.3 By Technology
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARRIER SCREENING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Myriad Genetics Inc
  • 10.2.2 Cepheid
  • 10.2.3 Illumina
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 F. Hoffmann-La Roche Ltd
  • 10.2.6 Laboratory Corporation Of America Holdings
  • 10.2.7 Otogenetics
  • 10.2.8 MedGenome
  • 10.2.9 GeneTech
  • 10.2.10 Centogene N.V